Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Aptar Pharma Revenue	1.74B	1.64B
Aptar Pharma Revenue Growth	5.74%	8.03%
Aptar Beauty Revenue	1.31B	1.23B
Aptar Beauty Revenue Growth	6.83%	-3.31%
Aptar Closures Revenue	730.26M	714.01M
Aptar Closures Revenue Growth	2.28%	2.18%
Revenue (Total)	3.78B	3.58B
Revenue (Total) Growth	5.42%	2.74%

Adjusted EBITDA

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Aptar Pharma Adjusted EBITDA	607.65M	568.37M
Aptar Pharma Adjusted EBITDA Growth	6.91%	13.08%
Aptar Beauty Adjusted EBITDA	158.77M	159.91M
Aptar Beauty Adjusted EBITDA Growth	-0.71%	-2.33%
Aptar Closures Adjusted EBITDA	116.48M	114.14M
Aptar Closures Adjusted EBITDA Growth	2.05%	10.08%
Corporate & Other Adjusted EBITDA	-67.79M	-67.50M
Operating Income (Other)	-314.06M	-278.43M
Operating Income (Total)	501.04M	496.50M
Operating Income (Total) Growth	0.92%	22.89%

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Aptar Pharma Core Sales Growth	3.00%	8.00%
Aptar Beauty Core Sales Growth	2.00%	-3.00%
Aptar Closures Core Sales Growth	1.00%	3.00%
Total Core Sales Growth	2.00%	3.00%

Updated Dec 31, 2025. Data Source: Fiscal.ai.